BiotechTube
Home/PDS Biotechnology/Frank Bedu-Addo, Ph.D.
FB

Frank Bedu-Addo, Ph.D.

Chief Executive Officer, Director

PDS Biotechnology

Therapeutic Areas

OncologyInfectious Diseases

PDS Biotechnology Pipeline

DrugIndicationPhase
PDS0101 (Versamune®-HPV)HPV16-positive Head and Neck Cancer (Recurrent/Metastatic)Phase 3
PDS01ADC + Versamune®3rd Line Metastatic CancerPhase 2
Versamune®-based TherapiesProstate CancerNot Specified
Infectimune®-based VaccinesSelected deadly infectious diseasesPreclinical/Research

Leadership Team at PDS Biotechnology

ST
Stephan Toutain
Chief Operating Officer
LB
Lars Boesgaard
Chief Financial Officer
GC
Gregory Conn, Ph.D.
Chief Scientific Officer
II
Ilian Iliev, Ph.D.
Director
GF
Gregory Freitag, J.D., CPA
Director
OW
Otis W. Brawley, M.D.
Director
View full PDS Biotechnology profile